Rosiglitazone on Microalbuminuria in Type 2 Diabetics

Clinical trial NCT00500955 · COMPLETED

Trial details

NCT number: NCT00500955
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2000-04-01
Enrollment: 336

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.